BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 32507359)

  • 21. Genetics of tumors of the adrenal cortex.
    Bonnet-Serrano F; Bertherat J
    Endocr Relat Cancer; 2018 Mar; 25(3):R131-R152. PubMed ID: 29233839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
    Stratakis CA; Boikos SA
    Nat Clin Pract Endocrinol Metab; 2007 Nov; 3(11):748-57. PubMed ID: 17955016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenocortical tumors, primary pigmented adrenocortical disease (PPNAD)/Carney complex, and other bilateral hyperplasias: the NIH studies.
    Stratakis CA
    Horm Metab Res; 2007 Jun; 39(6):467-73. PubMed ID: 17578766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primary aldosteronism : Genetics and pathology].
    Scholl U
    Pathologe; 2019 Dec; 40(Suppl 3):369-372. PubMed ID: 31705237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Insights into the Genetics and Pathophysiology of Adrenocortical Tumors.
    Drougat L; Omeiri H; Lefèvre L; Ragazzon B
    Front Endocrinol (Lausanne); 2015; 6():96. PubMed ID: 26106367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenocorticotropic hormone-independent Cushing's syndrome.
    Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
    Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions.
    Boikos SA; Horvath A; Heyerdahl S; Stein E; Robinson-White A; Bossis I; Bertherat J; Carney JA; Stratakis CA
    Horm Metab Res; 2008 May; 40(5):347-53. PubMed ID: 18491255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
    Åkerström T; Willenberg HS; Cupisti K; Ip J; Backman S; Moser A; Maharjan R; Robinson B; Iwen KA; Dralle H; D Volpe C; Bäckdahl M; Botling J; Stålberg P; Westin G; Walz MK; Lehnert H; Sidhu S; Zedenius J; Björklund P; Hellman P
    Endocr Relat Cancer; 2015 Oct; 22(5):735-44. PubMed ID: 26285814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unanswered Questions in the Genetic Basis of Primary Aldosteronism.
    Scholl UI
    Horm Metab Res; 2017 Dec; 49(12):963-968. PubMed ID: 29065434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of Phosphodiesterases in Adrenocortical Tumors.
    Hannah-Shmouni F; Faucz FR; Stratakis CA
    Front Endocrinol (Lausanne); 2016; 7():111. PubMed ID: 27625633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenal cortical tumors and multiple endocrine neoplasia-related syndromes.
    Haase M; Willenberg HS
    Minerva Endocrinol; 2009 Jun; 34(2):123-35. PubMed ID: 19471237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diseases Predisposing to Adrenocortical Malignancy (Li-Fraumeni Syndrome, Beckwith-Wiedemann Syndrome, and Carney Complex).
    Jouinot A; Bertherat J
    Exp Suppl; 2019; 111():149-169. PubMed ID: 31588532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics and epigenetics of adrenocortical tumors.
    Lerario AM; Moraitis A; Hammer GD
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):67-84. PubMed ID: 24220673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of disease: adrenocortical tumors--molecular advances and clinical perspectives.
    Bertherat J; Groussin L; Bertagna X
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):632-41. PubMed ID: 17082810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Causes of Functional Adrenocortical Adenomas.
    Zennaro MC; Boulkroun S; Fernandes-Rosa F
    Endocr Rev; 2017 Dec; 38(6):516-537. PubMed ID: 28973103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics of primary macronodular adrenal hyperplasia.
    Candida Barisson Villares Fragoso M; Pontes Cavalcante I; Meneses Ferreira A; Marinho de Paula Mariani B; Ferini Pacicco Lotfi C
    Presse Med; 2018; 47(7-8 Pt 2):e139-e149. PubMed ID: 30075949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sporadic adrenocortical tumors: genetics and perspectives for the pathologist].
    Tissier F
    Ann Pathol; 2008 Oct; 28(5):409-16. PubMed ID: 19068395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.
    Bimpaki EI; Nesterova M; Stratakis CA
    Eur J Endocrinol; 2009 Jul; 161(1):153-61. PubMed ID: 19429701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
    Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
    Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathogenesis of adrenocortical cancer].
    Szabó D; Zsippai A; Bendes M; Tömböl Z; Szabó PM; Rácz K; Igaz P
    Orv Hetil; 2010 Jul; 151(29):1163-70. PubMed ID: 20591784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.